Five-year survival and costs of care in metastatic colorectal cancer: conventional versus monoclonal antibody-based treatment protocols

Aleksandra Kovacevic, Viktorija Dragojevic-Simic, Dino Tarabar, Nemanja Rancic, Nemanja Jacimovic, Jelena Katic, Aleksandar Dagovic, Mihajlo Jakovljevic
  • Expert Review of Anticancer Therapy, June 2015, Taylor & Francis
  • DOI: 10.1586/14737140.2015.1059280

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Mihajlo (Michael) Jakovljevic MD, PhD